Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
75%(3 trials)

Phase Distribution

Ph phase_4
1
20%
Ph phase_2
2
40%
Ph phase_3
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 32 (40.0%)
Phase 41 (20.0%)

Trials by Status

not_yet_recruiting120%
completed480%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingphase_4

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

NCT07560618
completedphase_3

Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis

NCT06631170
completedphase_3

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

NCT04773587
completedphase_2

Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis

NCT03916081
completedphase_2

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

NCT03638258

Clinical Trials (5)

Showing 5 of 5 trials
NCT07560618Phase 4

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Not Yet Recruiting
NCT06631170Phase 3

Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis

Completed
NCT04773587Phase 3

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis

Completed
NCT03916081Phase 2

Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis

Completed
NCT03638258Phase 2

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5